- efixime trihydrate
- eftazidime sodium sterile
- efuroxime axetil / sodium sterile
- efotaxime sodium sterile
- eftriaxone sodium sterile
- efpodoxime proxetil comp ip/usp
- efpodoxime proxetil (micronised) ip
- ulbactam sodium sterile usp
- rioxsalen
- olnaftate
- erbutaline sulphat
- alcium D Pantothenate IP
- abergoline IP
Prasugrel Hydrochloride
CAS : 150322-43-3
Chemical formula : C20H20FNO3S
Indicated in combination with acetylsalicylic acid (ASA) to prevent atherothrombotic events in patients with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI). May be used in patients with unstable angina (UA), non-ST elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI) who are to be managed with PCI. Prasugrel is not recommended in patients 75 years of age or greater, those that weigh < 60kg, and patients with a history of stroke or transient ischemic attack due to increased risk of fatal and intracranial bleeding.